[Photo by Fusion Medical Animation on Unsplash]
The National Institutes of Health announced a $129.3 million plan to support scaling and manufacturing for COVID-19 tests.As part of its Rapid Acceleration of Diagnostics (RADx) initiative, NIH is awarding contracts to nine companies for their technologies that include portable point-of-care tests for immediate results and high-throughput laboratories that can produce results in 24 hours.
Yesterday’s announcement follows a July investment in seven companies from NIH worth $248.7 million in new technologies to address challenges with COVID-19 testing.
Some of the testing technologies are also being supported by the Biomedical Advanced Research and Development Authority (BARDA) as part of the U.S. Dept. of Health and Human Services, along with Defense Advanced Research Projects Agency (DARPA), in the U.S. Defense Dept.
Here are the nine co…